ArticleExperimental & molecular medicine2026

DN203316, a novel PPARδ agonist, suppresses ferroptotic signaling and fibrogenesis in metabolic dysfunction-associated steatohepatitis.

Ye Jin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.